The symptoms and signs of myocarditis are non-specific. Thus, myocarditis is a differential diagnosis in many patients with heart complaints. As clinical tools, such as history taking, physical examination, blood tests, the ECG, and the chest X-ray are not sufficient to ascertain the diagnosis of myocarditis, additional information from cardiac imaging techniques, or endomyocardial biopsy are necessary to confirm or exclude the disease. Echocardiography still represents the first-choice imaging modality in patients with a clinical suspicion of myocarditis, since it offers the acquisition of comprehensive anatomic and functional data very quickly at the bedside of the patient. Due to its non-invasiveness, the lack of radiation exposure, its image quality, which helps assessing and quantifying cardiac function, and its high tissue contrast, which can be modified using various pulse sequences, CMR has become an important technique for evaluating patients with suspected myocarditis. Emerging hybrid PET/CT and PET/MRI techniques may have considerable potential for future cardiovascular inflammation imaging because they combine PET, a highly sensitive and quantitative modality to detect even low-grade inflammation, with CT or MRI that enable non-invasive assessment of cardiovascular anatomy with excellent spatial resolution. However, when managing patients with inflammatory heart disease today, it should be kept in mind that endomyocardial biopsy remains the only technique that can directly assess the presence and intensity of myocardial inflammation in vivo. Therefore, it is the technique of choice if clinically indicated to differentiate between active and healed myocarditis.